NIH/WHO use inappropriate doses in trials to destroy cheap COVID treatments; Fluvoxamine is latest victim in the ACTIV-6 trial

RECOVERY, SOLIDARITY trials overdosed hydroxychloroquine; TOGETHER trial underdosed ivermectin

Fluvoxamine

The results of the NIH/ACTIV-6 fluvoxamine trial were recently published on the MedRxiv preprint server.

Previously, 100 mg of fluvoxamine twice a day was shown to be effective. We have mechanistic evidence that fluvoxamine (SSRI-Selective serotonin reuptake inhibitor) works as it is a mast cell stabilizer. The NIH/ACTIV-6 trial used only 50 mg twice a day. The ACTIV-6 study was designed to fail and produce headlines such as Study Debunks Use of Antidepressant Luvox as COVID Treatment. The Pharma conflicted authors have an obvious interest in destroying cheap, safe, effective treatments.

Ivermectin

For ivermectin the TOGETHER trial used an 18 mg dose for just one day, initially.

FLCCC experts recommend a dosage of up to 48 mg per day for 80kg weight, for at least 5 days.

Alexandros Marinos covers the TOGETHER trial ivermectin fraud in great detail. Dr.Pierre Kory also has more details.

Hydroxychloroquine

The RECOVERY and SOLIDARITY trials used near-fatal hydroxychloroquine overdoses and killed people in the trial.

Dr. Meryl Nass covers the details.